Evaluation of live attenuated S79 mumps vaccine effectiveness in mumps outbreaks: A matched case-control study

Chinese Medical Journal

Volumn 122, Issue 3, 2009, Pages 307-310

  Fu, Chuan Xi ^a   Nie, Jun ^a   Liang, Jian Hua ^a   Wang, Ming ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Case control studies; Mumps; Outbreaks

Indexed keywords

MUMPS VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CHINA; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MUMPS; PROTECTION; VACCINATION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INFANT; MALE; MUMPS; MUMPS VACCINE; VACCINES, ATTENUATED;

EID: 62749121548     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.03.013     Document Type: Article

References (21)

1. Baum SG. Who cares about mumps? You should! Clin Infect Dis 2008; 46: 1450-1451.
2. Centers for Disease Control and Prevention (CDC). Mumps epidemic-Iowa 2006. MMWR Dispatch 2006; 55: 1-3.
3. Centers for Disease Control and Prevention. Mumps epidemic - United kingdom, 2004-2005. MMWR 2006; 55: 175-177.
4. Enders M, Biber M, Exler S. Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 1393-1398.
5. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet 2008; 371: 932-944.
6. MacDonald N, Flegel K. Mumps in young adults: the canary in the coal mine. CMAJ 2007; 177: 121-123.
7. Stock I. Mumps - infectious disease with various faces. Med Monatsschr Pharm 2007; 30: 249-256.
8. WHO. Global status of mumps immunization and surveillance. Wkly Epidemiol Rec 2005; 44: 418-424.
9. Clements J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA 1996; 275: 390-397.
10. Fu C, Wang M, Liang J, He T, Wang D, Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine 2007; 25: 8756-8761.
11. Bernaola E, Herranz M, Clerigue N, Gil F. Case-control studies to assess vaccine effectiveness? Yes, but not this way. Clin Infect Dis 2007; 45: 1240-1241.
12. Brunell P. The effectiveness of evaluating mumps vaccine effectiveness. Clin Infect Dis 2007; 45: 467-469.
13. O'Brien KL, Levine OS. Effectiveness of pneumococcal conjugate vaccine. Lancet 2006; 368: 1469-1470.
14. Schaffzin JK, Pollock L, Schulte C, Henry K, Dayan G, Blog D. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007; 120: e862-e868.
15. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13: 12-17.
16. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005; 23: 4070-4074.
17. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008; 26: 3601-3607.
18. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45: 459-466.
19. Richard JL, Zwahlen M, Feuz M, Matter HC; Swiss Sentinel Surveillance Network. Comparision of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study. Eur J Epidemiol 2003; 18: 569-577.
20. Xu H, Tang Q. Partial nucleotide sequence analysis of vaccine and wild mumps viruses. Chin J Microbiol Immuol 1999; 19: 215-218.
21. Pugh RN, Akinosi B, Pooransingh S, Kumar J, Grant S, Livesley E, et al. An outbreak of mumps in the metropolitan area of Walsall, UK. Int J Infect Dis 2002; 6: 283-287.